BioSystics, Inc.

Our mission is to transform the rapidly evolving field of in vitro experimental models of disease and ADME/Tox ranging from traditional cell based assays to organoids and structured microphysiology systems through a comprehensive computational and systems biology analytics platform. The BioSystics platform accesses, manages, analyzes, shares and computationally models complex data sets from in vitro experimental models, animal models and human clinical data creating actionable knowledge and predicting biological outcomes that will accelerate and optimize drug discovery/development, as well as cosmetic, industrial and environmental chemical testing.